VANCOUVER, BRITISH COLUMBIA--(Marketwire - Jan. 10, 2012) - Pyng Medical Corp. (the "Company") (TSX VENTURE:PYT.V - News) announced today that the FAST1(R) has been chosen by the Spanish Army through ...
September 7, 2010 — The US Food and Drug Administration (FDA) has granted 510(k) clearance for a next-generation sternal intraosseous infusion system (FASTx; Pyng Medical Corp). The device is ...
Intraosseous vascular access is a technique in which the bone marrow cavity is used as a noncollapsible vascular entry point (Figure 1). It is considered to be the standard alternative to peripheral ...
The global industry for intraosseous infusion devices is poised for substantial growth, with an estimated value of USD 5,065.8 million in 2025. The market is expected to reach USD 10,463.8 million by ...
The global intraosseous infusion devices market is on a strong growth trajectory, with projections indicating a significant rise from USD 5,065.8 million in 2025 to USD 10,463.8 million by 2035. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback